Medtronic (MDT) reported fiscal Q3 non-GAAP earnings Tuesday of $1.36 per diluted share, down from $1.39 a year earlier.

Analysts polled by FactSet expected $1.34.

Net sales for the quarter ended Jan. 23 were $9.02 billion, compared with $8.29 billion a year earlier.

Analysts surveyed by FactSet expected $8.91 billion.

For 2026, the company reiterated its non-GAAP earnings guidance of between $5.62 to $5.66 per diluted share. Analysts polled by FactSet expect $5.65.